Summary
Castle Biosciences Inc (Castle Biosciences) is a diagnostic company that develops and commercializes diagnostic and prognostic tests for cancers. The company’s tests include cutaneous melanoma, uveal melanoma and glioblastoma multiforme. Its decisiondx-melanoma identifies stage I or II patients at high risk of metastasis. Castle Biosciences’ decisionDx-UM is prognostic tool that has become standard of care in eye cancer. The company offers clinician services. It works with commercial insurance providers to secure payment coverage for its diagnostic and prognostic tests. The company has presence in Canada, Israel, the US and Australia. Castle Biosciences is headquartered in Friendswood, Texas, the US.
Castle Biosciences Inc - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Castle Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Castle Biosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Castle Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Castle Biosciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Castle Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Castle Biosciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Castle Biosciences Raises USD11.7 Million in First Tranche of Series F Financing 10
Castle Biosciences Secures USD6 Million from Silicon Valley Bank 10
Castle Biosciences Raises USD11.8 Million in Series E Venture Financing 11
Castle Biosciences Raises US$1 Million In Venture Financing 12
Castle Biosciences Raises US$1 Million In Venture Financing 13
Castle Biosciences Raises USD1.5 Million in Venture Financing 13
Partnerships 14
Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test 14
Castle Biosciences Enters Into Licensing Agreement With Indiana University Research & Technology 15
Castle Biosciences Enters Into Licensing Agreement With Washington University 16
Castle Biosciences Inc - Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
May 09, 2016: Castle Biosciences Announces the Appointment of Bernhard E. Spiess as Chief Operating Officer 20
Legal and Regulatory 21
Jan 17, 2017: Castle Biosciences’ New Laboratory Receives Accreditation from College of American Pathologists 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Tables
Castle Biosciences Inc, Medical Equipment, Key Facts 1
Castle Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Castle Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Castle Biosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Castle Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Castle Biosciences Inc, Deals By Market, 2011 to YTD 2017 8
Castle Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Castle Biosciences Raises USD11.7 Million in First Tranche of Series F Financing 10
Castle Biosciences Secures USD6 Million from Silicon Valley Bank 10
Castle Biosciences Raises USD11.8 Million in Series E Venture Financing 11
Castle Biosciences Raises US$1 Million In Venture Financing 12
Castle Biosciences Raises US$1 Million In Venture Financing 13
Castle Biosciences Raises USD1.5 Million in Venture Financing 13
Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test 14
Castle Biosciences Enters Into Licensing Agreement With Indiana University Research & Technology 15
Castle Biosciences Enters Into Licensing Agreement With Washington University 16
Castle Biosciences Inc, Key Competitors 17
Castle Biosciences Inc, Key Employees 18
Castle Biosciences Inc, Other Locations 19
List of Figures
Castle Biosciences Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Castle Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Castle Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Castle Biosciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Castle Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Castle Biosciences Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Castle Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Castle Biosciences Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8